CAM
Crown Advisors Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.66M | Hold |
20,000
| – | – | 1.32% | 29 |
|
2025
Q1 | $1.62M | Hold |
20,000
| – | – | 1.43% | 30 |
|
2024
Q4 | $1.8M | Hold |
20,000
| – | – | 1.16% | 33 |
|
2024
Q3 | $1.98M | Hold |
20,000
| – | – | 1.27% | 30 |
|
2024
Q2 | $1.85M | Hold |
20,000
| – | – | 1.19% | 28 |
|
2024
Q1 | $1.9M | Hold |
20,000
| – | – | 1.15% | 29 |
|
2023
Q4 | $1.79M | Sell |
20,000
-20,000
| -50% | -$1.79M | 1.22% | 32 |
|
2023
Q3 | $2.92M | Hold |
40,000
| – | – | 2.08% | 21 |
|
2023
Q2 | $3.33M | Hold |
40,000
| – | – | 2.17% | 17 |
|
2023
Q1 | $3.05M | Buy |
40,000
+10,000
| +33% | +$762K | 2.28% | 18 |
|
2022
Q4 | $2.49M | Buy |
30,000
+5,000
| +20% | +$415K | 2.27% | 21 |
|
2022
Q3 | $1.98M | Buy |
+25,000
| New | +$1.98M | 1.97% | 23 |
|